We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

51 hedge funds and large institutions have $4.03M invested in Nymox Pharmaceutical Corp in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $60K | Put options by funds: $20K

14% less funds holding

Funds holding: 59 → 51 (-8)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

70% less capital invested

Capital invested by funds: $13.3M → $4.03M (-$9.28M)

Holders
51
Holders Change
-8
Holders Change %
-13.56%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
11
Reduced
14
Closed
21
Calls
$60K
Puts
$20K
Net Calls
+$40K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$568K
2
E
Ergoteles
New York
+$345K
3
TEE
Tibra Equities Europe
United Kingdom
+$280K
4
HF
HRT Financial
New York
+$223K
5
ECM
ExodusPoint Capital Management
New York
+$137K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.28M
2
State Street
State Street
Massachusetts
-$1.16M
3
Northern Trust
Northern Trust
Illinois
-$826K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$485K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$453K
Name Holding Trade Value Shares
Change 		Change in
Stake
GG
26
Gofen & Glossberg
Illinois
$40K – – –
WCWM
27
Willow Creek Wealth Management
California
$38K – – –
Brown Advisory
28
Brown Advisory
Maryland
$30K – – –
TRCT
29
Tower Research Capital (TRC)
New York
$28K +$23K +12,421 +248%
NFSG
30
Newbridge Financial Services Group
Florida
$21K +$24.1K +13,000 New
SFI
31
Susquehanna Fundamental Investments
Pennsylvania
$21K +$25K +13,500 New
CAM
32
Cubic Asset Management
Massachusetts
$20K +$2.5K +1,350 +12%
KAS
33
Kestra Advisory Services
Texas
$18K – – –
ODIJL
34
One Day In July LLC
Vermont
$16K +$18.5K +10,000 New
YIH
35
Y-Intercept (HK)
Hong Kong
$16K +$19.3K +10,391 New
Barclays
36
Barclays
United Kingdom
$14K -$49K -26,451 -75%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$14K +$7.14K +3,850 +77%
Wells Fargo
38
Wells Fargo
California
$12K -$408K -220,111 -97%
Simplex Trading
39
Simplex Trading
Illinois
$11K +$3.49K +1,885 +34%
Optiver Holding
40
Optiver Holding
Netherlands
$10K +$11.3K +6,109 New
UBS Group
41
UBS Group
Switzerland
$8K -$25.7K -13,864 -73%
BWA
42
BDO Wealth Advisors
Florida
$7K +$8.71K +4,700 New
Group One Trading
43
Group One Trading
Illinois
$6K +$5.38K +2,900 +281%
SIM
44
Sonora Investment Management
Arizona
$6K +$7.04K +3,800 New
Osaic Holdings
45
Osaic Holdings
Arizona
$4K – – –
SIAP
46
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$4K – – –
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$3.47K -$7.32K -3,947 -64%
Rockefeller Capital Management
48
Rockefeller Capital Management
New York
$3K – – –
Citigroup
49
Citigroup
New York
$1K -$5.19K -2,799 -89%
Northern Trust
50
Northern Trust
Illinois
– -$826K -371,944 Closed
1
2
3

NYMX Hedge Fund Activity: Q2 2021 in Review

51 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q2 2021, worth a combined $4.03M — down 70% from $13.3M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of NYMX and 13 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was Millennium Management, adding an estimated $568K. The largest seller was BlackRock, cutting an estimated $3.28M.

  • 51 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q2 2021, down from 59 in Q1 2021.
  • Funds reported $4.03M of Nymox Pharmaceutical Corp stock for Q2 2021, down 70% quarter-over-quarter.
  • 13 funds opened new Nymox Pharmaceutical Corp positions in Q2 2021 and 21 closed out, a net change of -8 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q2 2021 was Millennium Management, an estimated $568K added.
  • The largest Nymox Pharmaceutical Corp seller in Q2 2021 was BlackRock, an estimated $3.28M sold.

Based on aggregated 13F filings for Q2 2021.